<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1008222459
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ALEVE 220 mg film-coated tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        NAPROXEN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        220
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        11.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Bayer Bitterfeld GmbH " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Bayer Bitterfeld GmbH 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BAYER CONSUMER CARE AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AE02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        M02AA12
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Aleve contains the active substance naproxen as naproxen sodium. This relieves pain, lowers fever and is anti-inflammatory. The duration of action is 8&ndash;12 hours.<br />Aleve is suitable for short-term treatment, i.e. up to a maximum of 3 days, of:</p><ul><li>Back pain;</li><li>Pain in the joints and ligaments;</li><li>Pain following injury;</li><li>Period pains;</li><li>Toothache;</li><li>Headache;</li><li>Fever in connection with influenza-like illnesses.</li></ul><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>When should Aleve not be used</strong></p><ul><li>If you are allergic to one of the ingredients or suffer from shortness of breath or allergy-type skin reactions after taking acetylsalicylic acid or other analgesics or antirheumatics known as non-steroidal anti-inflammatory drugs</li><li>If you are pregnant or breast-feeding (see also &ldquo;Pregnancy and breast-feeding&rdquo;).</li><li>if you suffer from gastric and/or duodenal ulcers or gastrointestinal bleeding;</li><li>if you suffer from chronic bowel inflammation (Crohn&rsquo;s disease, ulcerative colitis).</li><li>if you have impaired liver or renal function.</li><li>if you have severe cardiac impairment.</li><li>for treatment of pain following coronary bypass surgery (or use of a heart-lung machine).</li><li>in children and adolescents under 16 years. Aleve film-coated tablets have not been tested for use in children and adolescents under 16 years of age.</li></ul><p><strong>Warnings and precautions</strong><br />During treatment with Aleve film-coated tablets, ulceration of the mucous membrane, bleeding<br />(rarely) or, in isolated cases, perforations (perforation of the stomach/bowel) may occur in the upper gastrointestinal tract. These complications may occur at any time during treatment, without warning symptoms. In order to minimise this risk, the smallest effective dose should be administered for the shortest possible period. Consult your doctor if you have stomach pain and suspect that this is connected with taking this medicine.<br />Older patients may react more sensitively to the medicine than younger adults. It is particularly important that older patients report possible side effects to their doctor immediately.<br />Aleve film-coated tablets should only be taken on prescription and under medical supervision in the following situations:</p><ul><li>if you are currently receiving medical treatment for a serious illness.</li><li>if you have previously had a gastric or duodenal ulcer.</li><li>if you have already had a myocardial infarction (heart attack), stroke or venous thrombosis, or if you have risk factors for these (such as high blood pressure, diabetes, high levels of blood fats, smoking); for a number of similarly acting painkillers (&laquo;COX-2 inhibitors&raquo;), an increased risk of heart attack and stroke has been seen at high doses and/or long term treatment. It is not known whether this increased risk also applies to Aleve film-coated tablets;</li><li>if you suffer from heart disease or kidney pain, assuming you are taking medicines for high blood pressure (e.g. diuretics, ACE inhibitors) or on increased fluid loss, e.g. as a result of heavy perspiration; taking Aleve film-coated tablets may impair your kidney function, which can lead to increased blood pressure and/or fluid retention (oedemas);</li><li>if you have liver disease;</li><li>if you are being treated with anti-coagulant drugs (blood thinners) or are suffering from a blood clotting disorder;</li><li>if you have asthma;</li><li>if you are taking antirheumatic drugs or other painkillers (e.g. acetyl salicylic acid, aspirin, ibuprofen;</li><li>if you are taking antiepileptic medicines (phenytoin), medicines for diabetes (other than insulin), diuretics (e.g. furosemide), gout treatments (probenecid), medicines containing sulfonamides to treat infections, or medicines containing lithium or methotrexate.</li></ul><p>The concomitant use of Aleve and low-dose acetylsalicylic acid (such as aspirin protect) should be avoided and should be used only after consultation with your doctor or health care professional. During treatment with Aleve, exposure of the skin to sunlight (UV rays) should be avoided as much as possible (see also &laquo;Possible side effects of Aleve&raquo;).<br />Inform your doctor of pharmacist if you:</p><ul><li>suffer from any other illnesses</li><li>have allergies or</li><li>are using other medicines (including those you purchase yourself!)</li></ul><p>Aleve may impair reactions, the ability to drive and the ability to operate tools or machines!</p><p><strong>Pregnancy and breast-feeding</strong><br /><em>Pregnancy</em><br />If you are pregnant or are planning to become pregnant, you should only take Aleve after consulting your doctor. Aleve must not be taken during the last three months of the pregnancy.<br /><em>Breast-feeding</em><br />Aleve should not be taken during breast-feeding unless specifically allowed by your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><em>Adults and adolescents over 16 years: </em>Take 1 film-coated tablet with plenty of liquid every 8 - 12 hours. If necessary, two tablets can be taken at the same time as an initial dose, followed if required by one tablet 12 hours later.<br /><em>Maximum daily dose:</em> Do not take more than 3 Aleve film-coated tablets within 24 hours, unless prescribed by a doctor.<br /><em>65 years and over: </em>Unless otherwise instructed by a doctor, not more than 2 tablets per day.</p><p><em>Treatment duration: </em>Do not use Aleve for longer than three days, and use it only to treat the symptoms described above.<br />If, despite taking Aleve, the symptoms do not get better or if the painful area becomes red or swollen, consult your doctor. Your symptoms could be caused by a serious illness.<br />Also, if the symptoms do not improve within three days at the latest, you should consult your doctor so that their cause can be discovered.</p><p><strong>Overdose</strong><br />A large overdose of naproxen may lead to drowsiness, sleepiness, upper abdominal pain, abdominal pain, indigestion, nausea, transient liver function disorders, hypoprothrombinaemia, renal impairment, metabolic acidosis, apnoea, disorientation or vomiting. Because Aleve is occasionally rapidly absorbed, high active substance concentrations in the blood can be expected shortly after administration. Some patients developed convulsions, but it is not clear whether or not these were related to naproxen.<br />If a patient accidentally or intentionally takes a large amount of products containing naproxen, the stomach should be emptied and the usual supportive measures taken. Animal tests indicate that the administration of 50 - 100 mg medicinal charcoal in the form of a thin slurry (over 15 minutes) within two hours of an overdose can significantly reduce absorption of the product.<br />As naproxen is highly protein bound, its plasma concentration cannot be reduced by haemodialysis.</p><p><strong>Children and adolescents under 16 years:</strong><br />Aleve should not be used by children and adolescents under 16 years. The use and safety of Aleve have not yet been systematically tested in children and adolescents under 16 years.<br />Always take the dosage stated in this package leaflet or prescribed by your doctor. If you think that the effect of the medicine is too weak or too strong, speak to your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The most usual side effects are: Headache, dizziness, drowsiness, abdominal pain, nausea and heartburn.<br />More rarely, insomnia, drowsiness, diarrhoea, vomiting, black stools, rashes, swelling of the face, feet or legs, and fever have been observed.<br />Photosensitivity reactions (sensitivity to light) are rare, but can be serious in some circumstances (see also &laquo;When should Aleve be used with caution?&raquo;).<br />The following side effects may occur after taking Aleve, and may require medical treatment:<br /><em>If one or more of the following symptoms occurs, please inform your doctor immediately and stop taking Aleve.</em></p><ul><li>Diarrhoea, flatulence, abdominal pains, heartburn or pain in the upper abdomen, vomiting, nausea.</li><li>Vomiting blood, blackened stools</li><li>Unusual tiredness, dizziness, severe headaches, confusion</li><li>Skin reactions such as rash, itching</li><li>Swelling on the face, feet or legs</li><li>Wheezing and shortness of breath</li><li>Chest pains and coughing</li><li>Blood in the urine</li></ul><p><strong>If you get any side effects,</strong> please tell your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.<br /><strong>To report any side effect(s):</strong><br />National Pharmacovigilance and Drug Safety Center (NPC).<br />Fax: + 966 - 11 - 205 - 7662.<br />Call NPC at +966 - 11 - 2038222,<br />Ext.: 2317 - 2356 - 2353 - 2354 - 2334 - 2340.<br />Toll - free: 8002490000.<br />E - mail: npc.drug@sfda.gov.sa.<br />Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store below 30&deg;C and protect from light.<br />The product must be stored out of the reach of children.<br />The product may only be used up to the date marked &ldquo;EXP&rdquo; on the container.<br />Your doctor and pharmacist have access to the detailed summary of product characteristics and will be happy to provide you with further information.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Aleve contains</strong><br />One oval film-coated tablet contains:</p><p><strong>Tablet Core:</strong><br /><u>Active Substance: </u>Naproxen sodium, consisting of 200 mg naproxen and 20 mg sodium.</p><p><u>Excipients: </u>Microcrystalline cellulose, Povidone K30, Talc, Magnesium stearate, Hydroxypropyl methylcellulose, Purified water.<br /><strong>Coating:</strong><br />Titanium dioxide, Polyethylene glycol 8000, Indigo carmine E132, Purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Pack sizes available
Pack: blister of 12 film-coated tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Made under license from <strong>Bayer Consumer Care AG</strong>,<br />Basel, Switzerland, by<br /><strong>Bayer Bitterfeld GmbH</strong>, Wolfen, Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This package leaflet was last reviewed in August, 2017.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي اليڤ على المادة الفعالة نابروكسين في هيئة نابروكسين صوديوم. وهو يقلل الألم ويقلل الحمى (يخفض درجة الحرارة المرتفعة) كما&nbsp;</p><p>أنه مضاد للالتهاب. وفنرة عمله تتراوح بين 8 - 12 ساعة. اليڤ مناسب للعلاج قصير المدى، أي بحد أقصى 3 أيام، من</p><p>ألم الظهر؛-<br />ألم المفاصل والأربطة؛-<br />الألم بعد الإصابة؛-<br />آلام الدورة الشهرية؛-<br />ألم الأسنان؛-<br />الصداع؛-<br />الحمى المصاحية للأمراض الشبيهة بالأنفلونزا-.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>متى لا يجب استخدام اليڤ</strong></p><p>&nbsp;.إذا كنت مصابا بالحساسية تجاه أحد المكونات أو كنت تعاني من ضيق النفس أو &nbsp;تفاعلات حساسية بالجلد بعد تناول حمض أسيتيل الساليسيليك &nbsp;(أسبرين) أو أي مسكنات أو &nbsp;أدوية أخرى مضادة للروماتيزم والمعروفة باسم الأدوية غير الستيرويدية المضادة للالتهابات -</p><p>.(&quot;إذا كنت حاملا أو ترضعين رضاعة طبيعية (انظري أيضا &quot;الحمل والرضاعة الطبيعية -<br />إذا كنت تعاني من قرحة في المعدة و / أو الاثني عشر أو &nbsp;نزيف معوي؛ -<br />(إذا كنت تعاني من التهاب الأمعاء المزمن (داء كرون أو التهاب القولون التقرحي -<br />إذا كنت تعاني من &nbsp;اختلال في وظائف الكبد أو الكلى -<br />.إذا كنت مصابا بقصور شديد في القلب -<br />.لعلاج الألم بعد جراحة تغيير الشرايين التاجية (أو استخدام جهاز القلب والرئة -</p><p>.في&nbsp;الأطفال والمراهقين أقل من 16 سنة. لم يتم اختبار أقراص اليڤ المغلفة للاستخدام في الأطفال والمراهقين أقل من 16 سنة&nbsp;-</p><p><strong>التحذيرات والاحتياطات</strong></p><p>&nbsp;أثناء العلاج بأقراص اليڤ المغلفة، من الممكن أن يحدث تقرح في الغشاء المخاطي، أو نزيف (نادرا)، أو في حالات منفردة، ثقوب (انثقاب المعدة</p><p>&nbsp;الأمعاء) في الجزء العلوي من الجهاز الهضمي. &nbsp;وقد تحدث هذه المضاعفات في أي وقت خلال فترة العلاج، بدون أعراض تحذيرية. ولتقليل /</p><p>&nbsp;هذه المخاطر، ينبغي تناول أقل جرعة فعالة لأقل فترة ممكنة. استشر طبيبك إذا كنت تعاني من ألم في المعدة وتشك أنه مرتبط بتناول</p><p>.هذا الدواء<br />من الممكن أن يتأثر المرضى من كبار السن بشكل أكثر حساسية عن البالغين الأصغر سنا. من المهم بصفة خاصة أن يقدم المرضى من كبار السن تقارير الآثار الجانبية المحتملة إلى الطبيب على الفور<br />:ينبغي أن يتم تناول أقراص اليڤ المغلفة بوصفة طبية وتحت الإشراف الطبي في الحالات التالية</p><p>إذا كنت تتلقى حاليا علاج طبي لأحد الأمراض الخطيرة -<br />إذا كنت قد أصبت مسبقا بقرحة في المعدة أو الاثنى عشر -<br />إذا كنت قد أصبت بالفعل باحتشاء عضلة القلب (أزمة قلبية)، أو سكتة دماغية أو جلطة وريدية، أو إذا كان لديك عوامل خطر للإصابة بهم (مثل ارتفاع ضغط الدم، أو مرض السكري، أو مستويات الدهون المرتفعة في الدم، أو التدخين)؛ ومع عدد من المسكنات التي تعمل بالمثل -</p><p>لوحظ زيادة خطر الاصابة بالنوبات القلبية والسكتة الدماغية مع الجرعات العالية و / أو &nbsp;في العلاج طويل المدى. ليس من المعروف ما إذا كان هذا الخطر المتزايد ينطبق أيضا على أقراص اليڤ المغلفة؛ ،(&laquo;COX2-مثبطات&raquo;)</p><p>إذا كنت تعاني من مرض في القلب أو ألم في الكلى، بفرض أنك تتناول أدوية لضغط الدم المرتفع (مثل مدرات البول، مثبطات الإنْزيم المحَُلِّوُ للأَْنَتوُينْسينِ) أو زيادة فقدان السوائل، مثل الناتج عن التعرق الشديد؛ إن تناول أقراص اليڤ المغلفة قد يؤدي إلى ضعف في وظائفُ الكلى والذي قد يؤدي إلى ارتفاع ضغط الدم و/ أو احتباس السوائل (الوذمات)؛<br />إذا كنت تعاني من مرض في الكبد؛ -<br />إذا كنت تُعالج بعقاقير مضادة لتجلط الدم (مسيلات الدم) أو تعاني من اضطراب في تخثر الدم -<br />إذا كنت تعاني من الربو؛ -<br />إذا كنت تتناول أدوية مضادة للروماتيزم أو مسكنات أخرى (مثل حمض أسيتيل الساليسيليك، الأسبرين، أيبوبروفين؛ -<br />،(إذا كنت تتناول أدوية مضادة للصرع مثل (فنيتوين)، أو أدوية لمرض السكري (بخلاف الإنسولين)، أو مدرات البول (مثل فيوروسيميد -</p><p>.أو علاجات النقرس (البروبينسيد)، أو الأدوية التي تحتوي على السلفوناميدات لعلاج العدوى، أو الأدوية التي تحتوي على الليثيوم أو ميثوتريكسات</p><p>يجب تجنب التناول المتزامن لعقار أليف مع جرعة منخفضة من حمض الأسيتيل ساليسيليك (مثل الأسبرين لحماية القلب) ولا يجب أن&nbsp;</p><p>.يُستخدم إلا بعد استشارة الطبيب المعالج لك أو أخصائي الرعاية الصحية المتابع لك</p><p>ينبغي تجنب التعرض لأشعة الشمس (الأشعة فوق البنفسجية) بقدر الإمكان أثناء العلاج باليڤ (انظر أيضا &laquo;الآثار الجانبية المحتملة</p><p>.(لاليڤ</p><p>:أخبر طبيبك أو الصيدلي إذا كنت</p><p>تعاني من أي أمراض أخرى -<br />مصاب بالحساسية أو -</p><p>(!تتناول أي أدوية أخرى (بما في ذلك تلك التي قمت بشرائها من تلقاء نفسك -</p><p>!من الممكن أن يؤثر اليڤ على ردود الأفعال، مثل القدرة على القيادة والقدرة على تشغيل الأدوات أو الآلات</p><p>&nbsp;</p><p><strong>الحمل والرضاعة الطبيعية</strong></p><p><u>الحمل</u><br />.إذا كنت حاملا أو تخططين لتصبحي حاملا، لا تتناولي اليڤ قبل أن تستشيري طبيبك. لا يجب تناول اليڤ خلال الأشهر الثلاثة الاخيرة من الحمل&nbsp;<br /><u>الرضاعة الطبيعية</u><br />.لا يجب تناول اليڤ أثناء الرضاعة الطبيعية إلا إذا سمح طبيبك بذلك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><u>للبالغين والمراهقين أكبر من 16 سنة</u>: تناول قرص مغلف 1 مع الكثير من السوائل كل 8 - 12 ساعة. إذا كان ضروريا، يمكن تناول قرصين معا كجرعة ابتدائية متبوعة بقرص واحد بعد 12 ساعة إذا لزم الأمر<br /><u>أقصى جرعة يومية:</u> لا تتناول أكثر من 3 أقراص اليڤ مغلفة خلال 24 ساعة ما لم يصف الطبيب خلاف ذلك<br /><u>سنة65&nbsp; وأكبر</u>: ما لم يصف الطبيب خلاف ذلك، فلا تتناول أكثر من قرصين في اليوم<br /><u>فترة العلاج:</u> لا تستخدم اليڤ لمدة تزيد عن ثلاثة أيام، واستخدمه فقط لعلاج الأعراض المذكورة أعلاه</p><p>إذا لم تتحسن الأعراض بالرغم من تناول اليڤ أو إذا أصبحت المناطق المؤلمة حمراء أو&nbsp; متورمة، استشيري طبيبك حيث أنه من الممكن أن تكون الأعراض لديك ناتجة عن مرض خطير<br />وكذلك إذا لم تتحسن الأعراض في خلال ثلاثة أيام على الأكثر، ينبغي أن تستشيري طبيبك حتى يتمكن من معرفة الأسباب</p><p><strong>الجرعة الزائدة</strong></p><p>&nbsp;إن جرعة زائدة كبيرة من نابروكسين قد تؤدي إلى الخمول، النعاس، آلام في&nbsp; الجزء العلوي من البطن، آلام في البطن، عسر الهضم، غثيان،&nbsp; اضطرابات في وظائف الكبد، نقص البروثرومبين (قصور في عملية تخثر الدم)، قصور كلوي،&nbsp; ارتفاع نسبة الحموضة في الدم، انقطاع&nbsp; النفس، ارتباك أو قيء. و لأن اليڤ يمتص بسرعة أحيانا، فإن تركيز المادة الفعالة يكون عاليا في الدم بعد فترة وجيزة من التناول. يصاب بعض المرضى بالتشنجات، ولكن ليس من الواضح ما إذا كانت هذه الاعراض مرتبطة بالنابروكسين.</p><p>إذا تناول مريض كمية كبيرة من منتجات تحتوي على نابروكسين عن قصد أو غير قصد، ينبغي إفراغ المعدة وعمل الإجراءات الداعمة&nbsp; اللازمة. التجارب على الحيوانات تشير إلى أن تناول 50-100 ملغ الفحم الطبي في شكل معجون رقيق القوام (لأكثر من 15 دقيقة) في&nbsp;</p><p>خلال ساعتين من تناول الجرعة الزائدة يمكن أن تقلل بشكل كبير من امتصاص المنتج<br />حيث ان النابروكسين يرتبط بشدة ببروتين الدم فالغسيل الكلوي لن يقلل من تركيزه في البلازما</p><p>الأطفال والمراهقين أقل من 16 سنة:</p><p>لا يجب استخدام اليڤ من قبل الأطفال والمراهقين أقل من 16 سنة. لم يتم اختبار سلامة اليڤ نظاميا في الأطفال والمراهقين أقل من 16 سنة بعد</p><p>قم دائما بتناول الجرعة المذكورة في هذه النشرة أو التي وصفها لك طبيبك. إذا كنت تعتقد أن تأثير الدواء شديد الضعف أو شديد القوة، أخبر طبيبك أو الصيدلي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>الآثار الجانبية الأكثر احتمالا هي: صداع، دوخة، نعاس، ألم في البطن، غثيان وحرقة في المعدة<br />والأكثر ندرة، لوحظ حدوث أرق، نعاس، وإسهال وقيء وبراز أسود، وطفح جلدي، وتورم في الوجه والقدمين أو الساقين، والحمى<br />تفاعلات الحساسية للضوء نادرة، ولكن يمكن أن تكون خطيرة في بعض الظروف (انظر أيضا &laquo;متى يجب أن تستخدم اليڤ بحذر؟&raquo;). الآثار الجانبية التالية يمكن أن تحدث بعد تناول اليڤ وقد تحتاج لعلاج طبي<br /><em>إذا حدث لك واحد أو أكثر من الأعراض التالية، فضلا أخبر طبيبك على الفور وتوقف عن تناول اليڤ</em></p><p>إسهال، وانتفاخ البطن، آلام في البطن، حرقة أو ألم في الجزء العلوي من البطن، تقيؤ وغثيان-</p><p>تقيؤ للدم، وبراز داكن اللون-<br />تعب غير عادي، ودوخة، وصداع شديد وارتباك-<br />تفاعلات جلدية مثل حكة وطفح-<br />ورم في الوجه أو القدمين أو الساقين-<br />أزيز وضيق في التنفس-<br />آلام في الصدر وكحة-<br />دم في البول-</p><p><strong>اذا تم اصابتك بأي آثار جانبية</strong>، من فضلك ابلغ طبيبك أو الصيدلي. هذا يشمل أي آثار جانبية غير مذكورة في هذه النشرة</p><p><strong>للإبلاغ عن الأعراض الجانبية</strong></p><p>المركز الوطني للتيقظ و السلامة الدوائية</p><p>+ فاكس: 7662&ndash; 205&ndash; 11 &ndash; 966</p><p>+ 966 &ndash; 11 &ndash; 2038222 للاتصال بالإدارة التنفيذية للتيقظ و إدارة الأزمات. هاتف</p><p>تحويلة: 2353&ndash; 2356&ndash; 2317&ndash; 2354&ndash; 2334&ndash; 2340</p><p>الهاتف المجاني: 8002490000<br />&nbsp; npc.drug@sfda.gov.sa البريد الالكتروني</p><p>www.sfda.gov.sa/npc&nbsp; الموقع الالكتروني</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp; يحفظ عند درجة حرارة أقل من 30 درجة مئوية و بعيداً عن الضوء<br />يجب حفظ المنتج بعيد عن متناول الأطفال<br />&nbsp;الموضوع على العبوة.&quot;EXP&quot;يمكن استخدام المنتج فقط حتى تاريخ<br />طبيبك والصيدلي يمكنهم الحصول على ملخص مفصل لخصائص المنتج وسوف يكونوا سعداء بتقدبم المزيد من المعلومات لك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>ما الذي يحتوي عليه اليڤ</strong></p><p>قرص واحد بيضاوي مغلف يحتوي على</p><p><strong>لب القرص</strong></p><p><u>المادة الفعالة </u>نابروكسين صوديوم والتي تتكون من 200 مجم نابروكسين و 20 مجم صوديوم</p><p>، تلك، ستيرات المغنسيوم، هيدروكسي بروبايل ميثيل سلولوز، ماء نقي.K30 <u>سواغات:</u> ميكروكريستالاين سلولوز، بوفيدون</p><p><strong>الكسوة الغشائية للقرص</strong><br />، ماء نقي.E132ثاني أكسيد التيتانيوم، بولي اثيلين جليكول 8000، انديجو كارمين</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            العبوات المتوفرة
العبوات: شريط به 12 قرص مغلف
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>، صنع بترخيص من<strong>&nbsp;باير كونسيومر كير إيه جي</strong></p><p>بازل، سويسرا. بواسطة</p><p><strong>باير بيترفلد جي ام بي إتش</strong>، ولفن، ألمانيا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة في أغسطس 2017.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ALEVE®
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 Aleve film-coated tablet contains 220 mg naproxen sodium, which is equivalent to 200 mg naproxen and 20 mg sodium.
Additives: Colour: Indigo carmine (E132), excipients for coated tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oval, light blue film-coated tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In self-medication, Aleve is approved for short-term treatment for a maximum of three days and for the following indications:</p><ul><li>Back pain,</li><li>Pain in the region of joints and ligaments,</li><li>Pain after injuries,</li><li>Menstrual pain,</li><li>Tooth pain,</li><li>Headaches,</li><li>Fever associated with influenzal illnesses.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Usual dosage&nbsp;</strong><br />Adults and adolescents aged 16 years and older:&nbsp;<br />1 film-coated tablet every 8 to 12 hours.&nbsp;<br />The starting dose may be two film-coated tablets, if necessary followed by one film-coated tablet 12 hours later.&nbsp;<br />Maximum dose for self-medication: Three Aleve film-coated tablets (600 mg naproxen) per 24 hours. Without medical prescription, Aleve is indicated for short-term treatment for a maximum of three days.</p><p><strong>Specific dosing instructions&nbsp;</strong><br />Older patients over the age of 65 years:&nbsp;If not prescribed otherwise, a maximum of two film-coated tablets per day.&nbsp;</p><p><br /><strong>Correct mode of administration&nbsp;</strong><br />The film-coated tablets to be taken whole with an adequate amount of water.&nbsp;<br /><em>Children and adolescents under the age of 16:&nbsp;</em><br />In self-medication, Aleve is not approved for use in children and adolescents under the age of 16.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                −	Hypersensitivity to the active ingredient or one of the excipients according to the composition.
−	A history of bronchial spasm, urticaria or allergy-like symptoms after the intake of acetylsalicylic acid or other non-steroidal antirheumatics.
−	Third trimester of pregnancy (see “Pregnancy/lactation”).
−	Active peptic and/or duodenal ulcers or gastrointestinal bleeding.
−	Inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis).
−	Severe liver dysfunction (liver cirrhosis and ascites).
−	Severe renal insufficiency (creatinine clearance <30 ml/min).
−	Severe cardiac insufficiency (NYHA III-IV).
−	Treatment of postoperative pain after coronary bypass surgery (or use of a heart-lung machine).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>General precaution for use of systemic non-steroidal antirheumatics:&nbsp;</em><br />During treatment with non-steroidal antirheumatics (NSAR), COX-2-selective or not, gastrointestinal ulcers, bleeding or perforations may occur at any time, even without warning symptoms or history. To reduce this risk, the smallest effective dose should be administered during the shortest possible therapy period.&nbsp;<br />In placebo-controlled studies, certain selective COX-2 inhibitors showed an increased risk of thrombotic cardiac and cerebrovascular complications. It is not known whether this risk is directly correlated with COX-1/COX-2 selectivity of the individual NSARs. Since no comparable clinical study data for the maximum dosage and long-term therapy of naproxen are currently available, a similar increased risk cannot be excluded. Until availability of relevant data, naproxen should be used for clinically documented coronary artery disease, cerebrovascular diseases, peripheral arterial occlusive disease or in patients with major risk factors (e.g., high blood pressure, hyperlipidaemia, diabetes mellitus, smoking) only after careful benefit-risk assessment. Also due to this risk, the smallest effective dose should be administered during the shortest possible therapy period.&nbsp;<br />Renal effects of NSARs include fluid retention with oedemas and/or arterial hypertension. In patients with impaired heart function and other conditions that predispose to fluid retention, naproxen should only be&nbsp;administered with caution. Caution should also be taken in patients on concurrent diuretics or ACE inhibitors as well as with an increased risk of hypovolaemia. &nbsp;</p><p><em>Caution should be taken in the following situations or Aleve must be taken only as prescribed and under medical supervision:</em>&nbsp;</p><p>&minus;&nbsp;&nbsp; &nbsp;In patients of advanced age, caution must be taken due to general medical considerations.<br />In addition, the plasma level of naproxen not bound to proteins is increased in elderly persons, although the total concentration level remains stable. It is particularly recommended to use the lowest possible effective dosage in frail elderly patients or in those with a low body weight.<br />&minus;&nbsp;&nbsp; &nbsp;In patients who are suffering or have previously suffered from bronchial asthma, naproxen may induce bronchial spasm.<br />&minus;&nbsp;&nbsp; &nbsp;In patients with renal insufficiency.<br />&minus;&nbsp;&nbsp; &nbsp;In patients with cardiac insufficiency.<br />&minus;&nbsp;&nbsp; &nbsp;In patients with liver dysfunction or hepatic insufficiency.<br />&minus;&nbsp;&nbsp; &nbsp;Haematologic effects: As with other non-steroidal anti-inflammatory drugs, naproxen may reduce platelet aggregation and prolong bleeding time.<br />This effect has to be taken into account when measuring the bleeding time. Patients with coagulation disorders or who receive medicinal therapies that impact homeostasis have to be carefully monitored during treatment with naproxen-containing products. Patients with a high bleeding risk as well as patients who are completely anticoagulated (e.g., with dicoumarol derivatives) may show a higher tendency for bleeding in case of concomitant administration of naproxen-containing products.</p><p><em>Renal impact&nbsp;</em><br />Caution must be taken in patients whose diseases lead to reduction in the blood volume and/or the renal blood flow and in whom renal prostaglandins support renal perfusion. In these patients, use of naproxen-containing products and other NSARs may lead to dose-dependent reduction of prostaglandin formation in the kidneys and induce manifest renal decompensation or renal failure. Patients treated with diuretics or ACE-inhibitors with renal dysfunction, hypovolaemia, cardiac insufficiency, liver dysfunction or hyponatraemia, as well as elderly patients, are at the highest risk in this regard. Naproxen-containing products have to be used with the greatest caution in these patients, and monitoring of the serum creatinine levels and/or creatinine clearance is recommended. To prevent the risk of excessive accumulation of naproxen metabolites in these patients, reduction of the daily dose should be considered.&nbsp;<br />Aleve is not recommended in patients whose baseline creatinine clearance is lower than 20 ml/min., because accumulation of naproxen metabolites has been observed in such cases.&nbsp;<br />Due to the high protein binding of naproxen, its plasma level cannot be reduced by haemodialysis.&nbsp;</p><p><em>Dermatologic effects&nbsp;</em><br />In rare cases, photosensitivity may occur. During treatment with naproxen, exposure to sunlight (UV light) should therefore be avoided, if possible.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Concomitant administration of antacids or cholestyramine as well as concomitant food intake may delay absorption of naproxen, but has no influence on the extent of absorption.&nbsp;<br />Due to the high plasma albumin binding of naproxen, interactions with other albumin-binding drugs, e.g., coumarin-type anticoagulants, sulphonylureas, hydantoins, other non-steroidal anti-inflammatory drugs and acetylsalicylic acid are potentially possible. Patients who are concomitantly treated with hydantoins (phenytoin), sulphonamides or sulphonylureas should be carefully monitored with regard to a potential dose adjustment.&nbsp;<br />Although clinical studies have shown no interactions between naproxen and anticoagulants or sulphonylureas, caution must be taken all the same, since interactions with other products of this substance class have been observed.&nbsp;<br />Naproxen can retard the irreversible inhibition of platelets induced by acetylsalicylic acid. Pharmacodynamic data suggest that the effect of low-dose acetylsalicylic acid on platelet activity is inhibited, once naproxen is taken for longer than one day concomitantly with low-dose acetylsalicylic acid. This effect may persist for several days after discontinuation of naproxen. The clinical relevance of this interaction is not known. Treatment with naproxen in patients with an increased cardiovascular risk may reduce the cardioprotective effect of acetylsalicylic acid. &nbsp;</p><p>Concomitant administration of probenecid increases the blood level and prolongs the biological half-life of naproxen.&nbsp;<br />In case of concomitant administration of Aleve and methotrexate, caution must be taken, because naproxen and some other non-steroidal anti-inflammatory drugs have demonstrated a reduced tubular secretion of methotrexate in an animal model, which may increase its toxicity.&nbsp;<br />Furthermore, naproxen can reduce the antihypertensive effect of beta-blockers.&nbsp;<br />It has been suggested that the natriuretic effect of furosemide is inhibited by some products of this substance class.&nbsp;<br />Inhibition of renal lithium clearance, which leads to increased lithium plasma levels, has also been reported.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Pregnancy:&nbsp;</em><br />Inhibition of prostaglandin synthesis may adversely affect pregnancy and/or the embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and of cardiac&nbsp;malformations, and gastroschisis after the use of a prostaglandin synthesis inhibitor in early pregnancy. The risk is thought to increase with the dose and duration of treatment. &nbsp;<br />Animal studies showed that administration of a prostaglandin inhibitor leads to increased pre- and post-implantation loss and to embryo/foetal lethality. Furthermore, increased incidence of several deformities, including cardiovascular deformities, was reported in animals receiving a prostaglandin inhibitor during organogenesis. &nbsp;<br />During the first and second trimester of pregnancy, naproxen should not be given unless clearly necessary. If naproxen is used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible. &nbsp;During the third trimester of pregnancy, naproxen is contraindicated. All prostaglandin inhibitors may: &nbsp;</p><ul><li>expose the foetus to the following risks:<ul><li>cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension);</li><li>renal dysfunction that may progress to renal failure with oligohydramniosis;</li></ul></li><li>expose mother and child to the following risks:<ul><li>possible prolongation of bleeding time, an anti-platelet aggregation effect which may occur even at very low doses;</li><li>inhibition of uterine contractions resulting in delayed</li><li>or prolonged labour.</li></ul></li></ul><p>Fertility: Use of naproxen may affect female fertility and is thus not recommended in women who plan to become pregnant. Women who have difficulty in becoming pregnant or who are undergoing infertility investigations should consider discontinuing naproxen.&nbsp;</p><p><em>Lactation:&nbsp;</em><br />NSARs pass into breast milk. As a precaution, naproxen should not be taken by lactating women. If treatment is essential, the infant should be switched to infant formula.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aleve may change reactivity so that the ability to drive or use machines may be affected (see chapter&nbsp;&laquo;Undesirable effects&raquo;).&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following undesirable effects have been observed for Aleve and higher doses of naproxen subject to prescription:&nbsp;<br /><em>Incidence</em>: Very common (&gt;1/10), common (&gt;1/100, &lt;1/10), uncommon (&gt;1/1000, &lt;1/100), rare (&gt;1/10,000, &lt;1/1,000), very rare (&lt;1/10,000).&nbsp;</p><p><em>Blood and lymphatic system&nbsp;</em><br /><em>Very rare</em>: Leukopenia, thrombocytopenia, agranulocytosis, aplastic anaemia, eosinophilia, haematolytic anaemia.&nbsp;</p><p><br /><em>Immune system</em>&nbsp;<br /><em>Very rare:</em> Anaphylaxis, anaphylactoid reactions, angioneurotic oedema.&nbsp;</p><p><br /><em>Psychiatric disorders&nbsp;</em><br /><em>Very rare:</em> Psychotic symptoms, depression, insomnia.&nbsp;</p><p><br /><em>Nervous system&nbsp;</em><br /><em>Common:</em> Headache, dizziness, drowsiness, tiredness.&nbsp;<br /><em>Very rare: </em>Aseptic meningitis, cognitive dysfunction, seizures.&nbsp;</p><p><em>Eyes&nbsp;</em><br /><em>Very rare</em>: Impaired vision, corneal clouding, papillitis, retrobulbar neuritis, papilloedema.&nbsp;</p><p><em>Ear and labyrinth&nbsp;</em><br /><em>Uncommon:</em> Vertigo.&nbsp;<br /><em>Very rare: </em>Auditory defects, tinnitus.&nbsp;</p><p><br /><em>Heart and vessels&nbsp;</em><br /><em>Very rare</em>: Cardiac insufficiency, hypertension, pulmonary oedema, vasculitis.&nbsp;</p><p><br /><em>Respiratory organs</em>&nbsp;<br /><em>Uncommon: </em>Dyspnoea, asthma.&nbsp;<br /><em>Very rare:</em> Eosinophilic pneumonia.&nbsp;</p><p><br /><em>Gastrointestinal disorders&nbsp;</em><br /><em>Common:</em> Dyspepsia, nausea, heartburn, abdominal pain.&nbsp;<br /><em>Uncommon</em>: Diarrhoea, obstipation, vomiting.&nbsp;<br /><em>Rare:</em> Peptic ulcers with or without bleeding/perforations, gastrointestinal bleeding, haematemesis, melaena.&nbsp;</p><p><em>Very rare:</em> Pancreatitis, colitis, aphthae, stomatitis, oesophagitis, intestinal ulceration.&nbsp;</p><p><em>Hepatobiliary disorders</em>&nbsp;<br /><em>Very rare:</em> Hepatitis, icterus.&nbsp;</p><p><em>Skin&nbsp;</em><br /><em>Uncommon:</em> Exanthemas (rash), pruritus, urticaria.&nbsp;<br /><em>Very rare:</em> Hair loss (mostly reversible), porphyria, Hebra&rsquo;s disease, epidermal necrolysis, erythema&nbsp;<br />nodosum, fixed drug exanthema, lichen ruber planus, pustular reaction, systemic lupus erythematosus,&nbsp;<br />photosensitivity including cases similar to symptomatic porphyria (&ldquo;pseudoporphyria&rdquo;) or epidermolysis bullosa.&nbsp;</p><p><br /><em>Renal and urinary tract&nbsp;</em><br /><em>Uncommon:</em> Renal dysfunction, oedema formation.&nbsp;<br /><em>Very rare:</em> Interstitial nephritis, papillary necrosis, nephrotic syndrome, acute renal insufficiency.&nbsp;</p><p><br /><em>Pregnancy-related, puerperal and perinatal symptoms&nbsp;</em><br /><em>Very rare: </em>Induction of labour.&nbsp;</p><p><br /><em>General disorders&nbsp;</em><br /><em>Rare:</em> Pyrexia.&nbsp;</p><p>&nbsp;</p><p><strong>To report any side effect(s)&nbsp;</strong><br />National Pharmacovigilance and Drug Safety Center (NPC).&nbsp;<br />Fax: + 966 - 11 - 205 - 7662.&nbsp;<br />Call NPC at +966 - 11 - 2038222,&nbsp;<br />Ext.: 2317 - 2356 - 2353 - 2354 - 2334 - 2340.&nbsp;<br />Toll - free: 8002490000.&nbsp;<br />E - mail: npc.drug@sfda.gov.sa.&nbsp;<br />Website: www.sfda.gov.sa/npc&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Severe overdose of naproxen may lead to drowsiness, somnolence, upper abdominal pain, abdominal problems, digestive problems, nausea, transient liver dysfunction, hypoprothrombinemia, renal&nbsp;<br />dysfunction, metabolic acidosis, apnoea, disorientation or vomiting. Because Aleve is sometimes quickly absorbed, high blood levels of the active ingredient are to be expected shortly after administration. Some&nbsp;<br />few patients experienced seizures; however, it is not clear whether they were related to naproxen or not. If a patient accidentally or deliberately takes a high number of naproxen-containing products, his/her&nbsp;<br />stomach should be emptied and the usual supportive measures taken. Tests in animals suggest that taking 50-100 g medicinal carbon (over the course of 15 minutes) in the form of a thin pur&eacute;e within two&nbsp;<br />hours after the overdose could considerably lower absorption of the product.&nbsp;<br />Due to the high protein binding of naproxen, its plasma level cannot be reduced by haemodialysis.&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>ATC code:</em> M01AE02<br />Aleve has analgesic, antipyretic and anti-inflammatory properties.&nbsp;<br />Naproxen is a non-selective COX inhibitor, the effect of which is based on the inhibition of the COX-1 and COX-2 enzymes. Naproxen inhibits formation of the COX-1-dependent thromboxane synthase A2 (TXA2), which leads to a reduction in the platelet aggregation, and in the COX-2-dependent prostacyclin (PGI2), an important vasodilatory mediator.&nbsp;<br />Naproxen inhibits the prostaglandin synthesis, which explains its analgesic and antiphlogistic effect.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Absorption&nbsp;</em><br />Naproxen sodium is rapidly and virtually completely absorbed in the gastrointestinal tract. After oral administration, peak active substance concentrations are reached within approximately one hour. Concomitant food intake may delay absorption of naproxen sodium, but does not affect the extent of absorption.&nbsp;<br /><em>Distribution&nbsp;</em><br />Naproxen has a volume of distribution of 0.16 l/kg. More than 99% of the active ingredient is bound to serum albumin. Doses exceeding 500 mg/day lead to non-proportional increase in the plasma levels, because higher doses lead to an increase of the clearance due to saturation of protein binding. On the other hand, increase of non-bound naproxen continues to be proportional to the administered dose. Naproxen passes into the synovial fluid, passes through the placenta barrier and was found in the milk of lactating mothers in concentrations equalling about 1% of the plasma level.&nbsp;</p><p><em>Metabolism&nbsp;</em><br />Naproxen is metabolised in the liver mainly into 6-O-desmethylnaproxen.&nbsp;<br /><em>Elimination&nbsp;</em><br />Approximately 95% of an Aleve dose is excreted by the kidneys as unchanged naproxen, inactive 6-O-desmethylnaproxen or in the form of naproxen conjugates. Small amounts (&le;3%) are excreted in the faeces.&nbsp;<br />The clearance of naproxen is 0.13 ml/min/kg. The biological plasma half-life is approximately 14 hours.&nbsp;</p><p><em>Kinetics of specific patient groups&nbsp;<br />Hepatic insufficiency&nbsp;</em><br />Patients with severely limited liver function may have increased plasma levels of unbound naproxen.&nbsp;<br /><em>Renal insufficiency&nbsp;</em><br />Because naproxen and its metabolites are excreted mainly by the kidneys, accumulation associated with renal insufficiency is basically possible. Elimination of naproxen is reduced in patients with severely limited renal function.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Carcinogenicity&nbsp;</em><br />Naproxen had been administered with food to Sprague-Dawley rats at doses of 8, 16 and 24 mg/kg/day for 24 months. Naproxen was not carcinogenic in rats.&nbsp;<br /><em>Mutagenicity&nbsp;</em><br />In Salmonella typhimurium (5 cell line), Saccharomyces cerevisiae (1 cell line) as well as in mouse lymphoma tests, no mutagenicity was observed.&nbsp;<br /><em>Fertility&nbsp;</em><br />Oral administration of naproxen doses of 30 g/kg/day in male rats and 20 mg/kg/day in female rats did not show any impact on fertility.&nbsp;<br /><em>Teratogenicity&nbsp;</em><br />Oral administration of naproxen at doses of 20 mg/kg/day during organogenesis did not show teratogenicity in rats and rabbits.&nbsp;</p><p><em>Perinatal/postnatal reproduction&nbsp;</em><br />Oral administration of naproxen to pregnant rats at doses of 2, 10 and 20 mg/kg/day during the third trimester caused complications during labour. This is a known effect of this substance class and has also been shown with acetylsalicylic acid and indomethacin.&nbsp;</p><p><br /><strong>Other particulars&nbsp;</strong><br /><em>Impact on diagnostic methods&nbsp;</em><br />Since Aleve may interfere with certain measurements of 17-ketosteroids, treatment should be discontinued 48 hours before performance of the adrenal gland function test. Similarly, Aleve may interfere with measurement of 5-hydroxyindolacetic acid in urine.&nbsp;</p><p>Naproxen leads to irreversible inhibition of platelet aggregation and prolongs bleeding time. This effect has to be taken into account when measuring the bleeding time.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline cellulose, Povidone K30, Talc, Magnesium stearate, Hydroxypropyl methylcellulose, Purified water.&nbsp;<br />Coating:&nbsp;<br />Titanium dioxide, Polyethylene glycol 8000, Indigo carmine E132, Purified water.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C. Store in original packagin g.&nbsp;<br />Do not use this medicine after the expiry date, which is stated on the container labelled &ldquo;EXP&rdquo;.&nbsp;<br />Keep out of the reach of children. &nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aleve film-coated tablets with 220 mg: 12 film-coated tablets [C]&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bayer Consumer Care AG, Switzerland
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                August 2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>